Pharmacological Diversity of Flavonoids and Their Clinical Application Prospects in Neurological Disorders
Phytotherapy Research · 2025-11 · 39 (11) · 5222-5248
DOI: 10.1002/ptr.70097 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2025-10. Written by Shuai Cheng and 8 co-authors. Institution: School of Basic Medical Sciences, Hebei University, Baoding, China. Major MEDLINE topics: Flavonoids, Nervous System Diseases. Cited 20 times so far (Crossref); 181 references. Funded by: Medical Science Foundation of Hebei University, Science and Technology Research Project of Universities in Hebei Province, Natural Science Foundation of Hebei Province.
Abstract (original language)
Flavonoids are a diverse group of polyphenolic compounds found in plant‐based foods and herbs, characterized by their varied hydroxylation and glycosylation patterns. Their complex molecular structures confer a wide range of pharmacological activities, including antioxidant effects through reactive oxygen species (ROS) scavenging and Nrf2 activation, anti‐inflammatory properties via NF‐κB inhibition, anti‐apoptotic effects, and modulation of ion channel activities. These mechanisms make flavonoids promising candidates for therapeutic applications across various conditions, including neurological disorders, cardiovascular diseases, cancer, and metabolic disorders. Specifically, inflammation and ion channel dysfunction are common underlying factors in many diseases, positioning flavonoids as potential multi‐target interventions. For instance, apigenin and vitexin are natural, safe alternatives for treating neuroinflammatory conditions such as multiple sclerosis, offering efficacy with minimal side effects. This review categorizes flavonoids based on their structural characteristics and explores their advancements in addressing inflammation, oxidative stress, apoptosis, ion channel regulation, pain relief, and neurological disorders, including epilepsy, Alzheimer's disease, Parkinson's disease, and anti‐stroke. Ultimately, the review underscores the need for further high‐quality studies to firmly establish the clinical efficacy of these plant‐derived compounds, alongside research into optimal dosing and formulation strategies, highlighting their potential as multi‐faceted therapeutic agents for neurological disorders.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Basic Medical Sciences, Hebei University, Baoding, China.
- Affiliated Hospital of Hebei University, Baoding, China.
ORCID profiles: Shuai Cheng
Funding
- Medical Science Foundation of Hebei University
- Science and Technology Research Project of Universities in Hebei Province
- Natural Science Foundation of Hebei Province
Cite
APA
Cheng, S., Gao, H., Yang, Y., Zhang, M., Wang, J., Li, N., Ji, Y., Wang, H., & Zhou, Y. (2025). Pharmacological Diversity of Flavonoids and Their Clinical Application Prospects in Neurological Disorders. Phytotherapy Research, 39(11), 5222-5248. https://doi.org/10.1002/ptr.70097
Vancouver
Cheng S, Gao H, Yang Y, Zhang M, Wang J, Li N, et al. Pharmacological Diversity of Flavonoids and Their Clinical Application Prospects in Neurological Disorders. Phytotherapy Research. 2025;39(11):5222-5248. doi:10.1002/ptr.70097
BibTeX
@article{Cheng2025,
author = {Cheng, Shuai and Gao, Hongwei and Yang, Yaxing and Zhang, Mengxue and Wang, Jing and Li, Na and Ji, Yonghua and Wang, Hongjie and Zhou, You},
title = {Pharmacological Diversity of Flavonoids and Their Clinical Application Prospects in Neurological Disorders},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {11},
pages = {5222--5248},
doi = {10.1002/ptr.70097}
}
EUVIMED